[Behavior of alanine aminopeptidase excretion after administration of Visotrast as diagnostic means].
D000409:Alanine; D000626:Aminopeptidases / Q000652:urine*; D002761:Cholangitis / Q000000981:diagnostic imaging; D002769:Cholelithiasis / Q000000981:diagnostic imaging; D003287:Contrast Media / Q000008:administration & dosage*; D006689:Hodgkin Disease / Q000000981:diagnostic imaging; D006801:Humans; D007674:Kidney Diseases / Q000000981:diagnostic imaging; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging; D010954:Plasmacytoma / Q000000981:diagnostic imaging; D011704:Pyelonephritis / Q000000981:diagnostic imaging; D011859:Radiography; D014545:Urinary Calculi / Q000000981:diagnostic imaging
D003287:Contrast Media; D000626:Aminopeptidases; D000409:Alanine
Das Verhalten der Alaninaminopeptidase-Ausscheidung nach Visotrastapplikation als diagnostischer Test